US Patent Issued to Verily Life Sciences on Oct. 28 for "Continuous detection and monitoring of heart arrhythmia using both wearable sensors and cloud-resident analyses" (California Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,453,471, issued on Oct. 28, was assigned to Verily Life Sciences LLC (Dallas).

"Continuous detection and monitoring of heart arrhythmia using both wearable sensors and cloud-resident analyses" was invented by Mark Murphy (Mountain View, Calif.) and Nikhil Bikhchandani (San Francisco).

According to the abstract* released by the U.S. Patent & Trademark Office: "Systems and methods are provided for continuously monitoring a user to determine when cardiovascular events are likely occurring and to responsively provide a prompt to a user to engage in additional physiological assessment of the putative cardiovascular event. Additional assessment can include the user engaging an additional s...